Albany, NY -- (SBWIRE) -- 05/04/2016 -- In a report presented by Transparency Market Research (TMR), the global pyrogen testing market is analyzed ground-up for the 2015-2023 period. It covers market trends and growth paradigms observed in the past and currently, based on which these indicators are evaluated for the future. The emergence of new bacterial variants and presence of bacterial toxins in drugs and vaccines that manifest as certain indications are also looked into herein. The title of this report is, "Pyrogen Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023."

The companies that are at forefront of the global pyrogen testing market are Thermo Fisher Scientific Inc., Ellab A/S, Genscript, Wako Chemicals USA Inc., Merck & Co. Inc., Charles River Laboratories International Inc., Hyglos GmbH, Sigma-Aldrich Corporation, Lonza Group, Associates of Cape Cod Inc., and Waters Corporation. These companies are profiled for their product portfolio, recent developments, business overview, and SWOTs in the report; an overview of strengths, weaknesses, threats, and opportunities of this market until the end of the forecast period is also included herein.

Pyrogens are predominantly bacterial toxins that manifest in the form of fever in the human body. Pyrogen testing is carried out to determine their presence in the bloodstream. Conventionally, rabbits were injected with drugs to determine the presence of pyrogen substances; however, advanced tests are performed using blood cells derived from a horseshoe crab to establish if pyrogens are present in the bloodstream.

The report states the reasons that are driving the global pyrogen testing market. The rapid expansion of the pharmaceutical industry as well as the medical devices and biotechnology sectors is primarily driving this industry. Increasing government support for clinical trials for discovering disease pathogens is resulting in the launch of new drugs and is thus boosting the growth of the pyrogen testing market. On the other hand, strict regulatory stipulations that drug manufacturers need to adhere to are limiting this market's growth.

Get a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4583

In terms of geography, North America, Asia Pacific, Europe, and Rest of the World are the regional segments of the pyrogen testing market. The North America regional market comprises pyrogen testing markets of the U.S. and Canada cumulatively. Likewise, the Europe market comprises the pyrogen testing markets of Germany, France, Italy, Spain, and Rest of Europe (RoE). Currently, North America and Europe are the largest markets for pyrogen testing. This is attributable to the presence of a highly advanced R&D infrastructure and substantial government funding for new drug discovery and launch of medical devices. A well-defined regulatory framework in place for monitoring practices that are related to public health are reasons for the dominance of North America and Europe in pyrogen testing.

Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/